Skip to main content
PEN $327.02 +0.08%
PEN logo

PEN · Penumbra Inc

Track PEN — free
$327.02 +0.27 (+0.08%) At close · Aug 14
Market Cap
$12.88B
Shares
39.39M
All earnings calls

Earnings call · FY2026 Q2

Penumbra Inc Q2 FY2026 Earnings Call

Penumbra Inc Q2 FY2026 Earnings Call

Concluded Jul 30, 2026
Jul 30, 2026 0 turns
Period
FY2026 Q2
Runtime
Sources
2 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Research coverage

2 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $390.05M +14.9% YoY
Diluted EPS $0.88 -23.5% YoY
Gross margin 67.9% +1.9 pp YoY
Net income $34.81M -23.1% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Thrombectomy$258.98M +12.5% YoY
Embolization and Access$131.06M +20% YoY
Full-screen source Call document